drugset / Trial / NCT05160623

Treatment of Blepharitis With Povidone-Iodine 1%

NCT05160623

Unknown 100 enrolled Shaare Zedek Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

One hundred blepharitis patients will be recruited. Each patient will treat one eye once daily with 1% PVI for 30 days by scrubbing the eyelid margin with the solution. The fellow eye will serve as the control and be given the standard treatment (commercial eye wipes). Before treatment initiation, various ocular surface variables will be assessed, such as dry eye grading, subjective discomfort scales, ocular surface questionnaire, and other clinical signs. After 30 days, an identical evaluation will be performed.

Timeline

Start
2021-08-16
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 1 % Topical

Indications